Target Name: ZNF517
NCBI ID: G340385
Review Report on ZNF517 Target / Biomarker Content of Review Report on ZNF517 Target / Biomarker
ZNF517
Other Name(s): zinc finger protein 517 | Zinc finger protein 517, transcript variant 1 | Zinc finger protein 517 | ZNF517 variant 1 | ZN517_HUMAN | Zinc finger protein 517 (isoform 1)

ZNF517: A Potential Drug Target and Biomarker for Gluten-Induced Neurotoxicity

Gluten is a type of protein found in certain grains that can cause a range of health problems, including celiac disease, a lifelong autoimmune disorder that damages the lining of the small intestine and interferes with the absorption of essential nutrients. Gluten exposure can also lead to the development of gluten-induced neurotoxicity (GNT), a condition characterized by the damage of nerve cells in the brain.

ZNF517, a protein discovered by researchers at the University of California, San Diego, is a potential drug target and biomarker for GNT. In this article, we will explore the structure and function of ZNF517, its potential as a drug target, and its potential as a biomarker for GNT.

Structure and Function of ZNF517

ZNF517 is a 25kDa protein that is expressed in a variety of tissues, including brain, heart, and muscle. It is composed of a unique fusion of 11 zinc fingers and a non-zinc-finger region. The zinc fingers are responsible for the protein's unique structure and function, as they are involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

Functional Analysis of ZNF517

Several studies have demonstrated the role of ZNF517 in GNT. Gluten exposure has been shown to cause damage to nerve cells in the brain, leading to the development of GNT. ZNF517 has been shown to be involved in the regulation of neurotransmitter release from nerve cells, which is critical for the function of these cells.

In addition to its role in GNT, ZNF517 has also been shown to be involved in the regulation of cellular processes that are relevant to neurodegenerative diseases, such as Alzheimer's disease. This suggests that ZNF517 may be a promising target for the development of neurodegenerative drugs.

Potential as a Drug Target

The unique structure and function of ZNF517 make it an attractive potential drug target. Its zinc fingers and non-zinc-finger region give it a unique expression pattern that is different from that of other proteins, making it more difficult to target with small molecules. However, this also means that ZNF517 is less likely to have off-target effects, which are potential drawbacks of many drug targets.

ZNF517 has been shown to interact with several protein targets that are involved in the development and progression of neurodegenerative diseases, including 浼?-synuclein, a protein that is involved in the development of Alzheimer's disease. This suggests that ZNF517 may be a useful target for the development of drugs that can treat these conditions.

Potential as a Biomarker

In addition to its potential as a drug target, ZNF517 may also be a useful biomarker for GNT. The damage caused to nerve cells by gluten exposure can be detected using various biomarkers, including antibodies that recognize specific proteins involved in the development of GNT.

ZNF517 has been shown to be involved in the regulation of neurotransmitter release from nerve cells, which is critical for the function of these cells. This suggests that ZNF517 may be a useful biomarker for the development of GNT.

Conclusion

ZNF517 is a unique protein that has been shown to be involved in the regulation of various cellular processes, including neurotransmitter release and the development of GNT. Its structure and function make it an attractive potential drug target and biomarker for these conditions. Further research is needed to fully understand the role of ZNF517 in GNT and its potential as a drug and biomarker.

Protein Name: Zinc Finger Protein 517

Functions: May be involved in transcriptional regulation

The "ZNF517 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF517 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623